Related references
Note: Only part of the references are listed.Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma
Joseph C. Ahn et al.
HEPATOLOGY (2021)
A global investment framework for the elimination of hepatitis B
Jessica Howell et al.
JOURNAL OF HEPATOLOGY (2021)
β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma
Yanwei Lu et al.
ONCOGENE (2021)
Effect of let-7c on the PI3K/Akt/FoxO signaling pathway in hepatocellular carcinoma
Yuehua Li et al.
ONCOLOGY LETTERS (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
Jose D. Debes et al.
CANCERS (2021)
MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
Hyuk Moon et al.
CANCERS (2021)
Tumor-Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma
Zongyi Yang et al.
HEPATOLOGY (2020)
miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling
Zheng Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Systems and Synthetic microRNA Biology: From Biogenesis to Disease Pathogenesis
Hironori Matsuyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis
Li Gu et al.
ONCOGENE (2020)
The expression level and diagnostic value of microRNA-22 in HCC patients
Zhen Zeng et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2020)
MicroRNA signature in hepatocellular carcinoma patients: identification of potential markers
Mohammed Elhendawy et al.
MOLECULAR BIOLOGY REPORTS (2020)
Circulating miR-16-5p, miR-92a-3p, and miR-451a in Plasma from Lung Cancer Patients: Potential Application in Early Detection and a Regulatory Role in Tumorigenesis Pathways
Patricia P. Reis et al.
CANCERS (2020)
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights
Di-Yang Xie et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Thymoquinone potentiates miR-16 and miR-375 expressions in hepatocellular carcinoma
Aya O. Bashir et al.
LIFE SCIENCES (2020)
Identification of Circulating miR-22-3p and miR-93-5p as Stable Endogenous Control in Tuberculosis Study
Workneh Korma et al.
DIAGNOSTICS (2020)
microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis
Tiziana Annese et al.
FRONTIERS IN ONCOLOGY (2020)
Circulating miR-1246 in the Progression of Chronic Obstructive Pulmonary Disease (COPD) in Patients from the BODE Cohort
Sara Cazorla-Rivero et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma
Jonggi Choi et al.
HEPATOLOGY (2019)
A Large-Scale Multicenter Study Validates Aldo-Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma
Xu Ye et al.
HEPATOLOGY (2019)
Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1 and activation of the ERK/MAPK signaling pathway
Lei Kong et al.
CELL CYCLE (2019)
p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma
Beilei Zhang et al.
CANCER LETTERS (2019)
Systematic Assessment of Blood-Borne MicroRNAs Highlights Molecular Profiles of Endurance Sport and Carbohydrate Uptake
Fabian Kern et al.
CELLS (2019)
SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma
Liangliang Xu et al.
CLINICAL SCIENCE (2019)
The clinical potential of circulating microRNAs in obesity
Chenbo Ji et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients
Mona Zaky Nasser et al.
ARAB JOURNAL OF GASTROENTEROLOGY (2019)
mirDIP 4.1-integrative database of human microRNA target predictions
Tomas Tokar et al.
NUCLEIC ACIDS RESEARCH (2018)
Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients
Lobna Mourad et al.
CANCER BIOLOGY & THERAPY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Decoupling the impact of microRNAs on translational repression versus RNA degradation in embryonic stem cells
Jacob W. Freimer et al.
ELIFE (2018)
KEGG: new perspectives on genomes, pathways, diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2017)
Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
Khalda S. Amr et al.
GENES & DISEASES (2017)
miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways
Qingmei He et al.
ONCOTARGET (2016)
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
Alexander A. Svoronos et al.
CANCER RESEARCH (2016)
Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection
Abdel-Rahman Nabawy Zekri et al.
TUMOR BIOLOGY (2016)
miR-122-A key factor and therapeutic target in liver disease
Simonetta Bandiera et al.
JOURNAL OF HEPATOLOGY (2015)
microRNAs for peripheral blood fraction identification: Origin, pathways and forensic relevance
Maria Teresa Machado et al.
LIFE SCIENCES (2015)
Different Normalization Strategies Might Cause Inconsistent Variation in Circulating microRNAs in Patients with Hepatocellular Carcinoma
Gusheng Tang et al.
MEDICAL SCIENCE MONITOR (2015)
miRDB: an online resource for microRNA target prediction and functional annotations
Nathan Wong et al.
NUCLEIC ACIDS RESEARCH (2015)
SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma
P. Y. Hernanda et al.
ONCOGENE (2015)
Methodological challenges in utilizing miRNAs as circulating biomarkers
Leni Moldovan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma
Hassan El-Garem et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease
Bin Xiao et al.
BLOOD (2013)
MicroRNAs: New Tools for Diagnosis, Prognosis, and Therapy in Hepatocellular Carcinoma?
Silvia Giordano et al.
HEPATOLOGY (2013)
Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis
Jonel Trebicka et al.
JOURNAL OF HEPATOLOGY (2013)
Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3
Bo Ling et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Liver-specific microRNA-122 Biogenesis and function
Catherine L. Jopling
RNA BIOLOGY (2012)
Extracellular miRNAs: the mystery of their origin and function
Andrey Turchinovich et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma
Kevin Z. Qu et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis
Peng Gao et al.
JOURNAL OF HEPATOLOGY (2011)
MicroRNA-22 Regulates Hypoxia Signaling in Colon Cancer Cells
Munekazu Yamakuchi et al.
PLOS ONE (2011)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis
Y Zhao et al.
NATURE (2005)
Share Paper
